Fujian Cosunter Pharmaceutical Co.Ltd(300436)
Occupation of funds by controlling shareholders and other related parties
Special description
Dahuhezi [2022] No. 007793
Da Hua Certified Public Accountants (special general partnership)
Fujian Cosunter Pharmaceutical Co.Ltd(300436)
Special instructions on the occupation of funds by controlling shareholders and other related parties
(as of December 31, 2021)
Table of contents page I. special 1-2 description of capital occupation by controlling shareholders and other related parties
2、 Fujian Cosunter Pharmaceutical Co.Ltd(300436) summary of non operating capital occupation and other related capital transactions in 2021
surface
Dahua Certified Public Accountants (special general partnership) 12 / F, building 7, No. 16 courtyard, Middle West Fourth Ring Road, Haidian District, Beijing [100039] Tel: 86 (10) 58350011 Fax: 86 (10) 58350006 www.dahua-cpa com. Special instructions on the occupation of funds by controlling shareholders and other related parties
Dahuhezi [2022] 007793 Fujian Cosunter Pharmaceutical Co.Ltd(300436) all shareholders:
We have been entrusted to audit the financial statements of Fujian Cosunter Pharmaceutical Co.Ltd(300436) (hereinafter referred to as Fujian Cosunter Pharmaceutical Co.Ltd(300436) company) in 2021, including the consolidated and parent company's balance sheet as of December 31, 2021, the consolidated and parent company's income statement, consolidated and parent company's cash flow statement, consolidated and parent company's statement of changes in shareholders' equity and notes to financial statements in 2021 in accordance with the practice standards of Chinese certified public accountants, On April 21, 2022, the company issued an unqualified audit report in accordance with dhsz [2022] No. 0010676.
In accordance with the provisions of the regulatory guidelines for listed companies No. 8 - regulatory requirements for capital exchanges and external guarantees of listed companies (CSRC announcement [2022] No. 26) and the self regulatory guidelines for GEM listed companies of Shenzhen Stock Exchange No. 1 - business handling issued by Shenzhen Stock Exchange, Issue special instructions on the summary statement of non operating capital occupation and other related capital transactions in 2021 (hereinafter referred to as the "summary statement") prepared by Fujian Cosunter Pharmaceutical Co.Ltd(300436) company.
It is the responsibility of the management of Fujian Cosunter Pharmaceutical Co.Ltd(300436) company to truthfully prepare and disclose the summary and ensure its authenticity, legitimacy and integrity. We have checked the information contained in the summary with the accounting information reviewed and the relevant contents of the audited financial statements when we audited the 2021 financial statements of Fujian Cosunter Pharmaceutical Co.Ltd(300436) company, and found no inconsistency in all major aspects. except
Dahuhezi [2022] 007793 special instruction
In addition to the audit procedures related to related party transactions in the audit of financial statements of Fujian Cosunter Pharmaceutical Co.Ltd(300436) company in 2021, we did not perform additional audit procedures on the information contained in the summary. In order to better understand the occupation of funds by the controlling shareholders and other related parties of Fujian Cosunter Pharmaceutical Co.Ltd(300436) company in 2021, the attached summary shall be read together with the audited financial statements.
This special instruction is issued in accordance with the requirements of China Securities Regulatory Commission and its dispatched offices and Shenzhen Stock Exchange, and shall not be used for other purposes. The consequences caused by improper use have nothing to do with the certified public accountants and accounting firms performing the business.
Annex: Fujian Cosunter Pharmaceutical Co.Ltd(300436) 2021 summary of non operating capital occupation and other related capital transactions Dahua Certified Public Accountants (special general partnership) Chinese Certified Public Accountants:
(project partner) Wang Qinglian
Beijing, China
Chinese certified public accountant:
Lai Zhenye
April 21, 2002
Summary of occupation of non operating funds and other related capital transactions in 2021
Prepared by: Fujian Cosunter Pharmaceutical Co.Ltd(300436) unit: 10000 yuan
Non operating occupiers and listed companies at the beginning of 2021, the cumulative occupation of 2021 in 2021, the occupation of 2021 in 2021
Fund occupation the related relationship between the name of the fund occupier and the company will be used to calculate the amount of the occupied Fund (the interest without the fund will be repaid to the accumulated end occupied fund to form the account balance of the nature of occupation, including interest) the reason for the amount of interest (if any) and the balance of the fund
Controlling shareholders, actual controlling non operating occupiers and their affiliated enterprises
Subtotal————
Former controlling shareholders, actual controlling non operating occupiers and their subsidiaries
Subtotal————
Other related parties and their affiliated non operating enterprises
Subtotal -——
Total————
Transactions between other related parties and listed companies at the beginning of 2021 and the year 2021 have accumulated the nature of transactions from 2021 to 2021 (the amount of current funds calculated by the name of the related relationship between the operating capital and the company) (repayment of interest from non funds, accumulated end of transaction capital, formative transaction, non operating account balance including interest) interest (if any) amount and reason transaction)
Controlling shareholder and actual control
Person and its affiliated enterprises
Subsidiaries of listed companies and other receivables of Fujian Fujian Cosunter Pharmaceutical Co.Ltd(300436) Jintang pharmaceutical holding subsidiaries 2 China Vanke Co.Ltd(000002) 00000 non operating transactions with its subsidiaries Co., Ltd
Other related parties and their affiliates
enterprise
Total - 200000 -
